Consolidated Statements of Cash Flows - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2023	Mar. 31, 2022
Cash flows from operating activities:
Net income	$ 1,595	$ 982
Adjustments to reconcile net income to net cash provided by (used in) operating activities:
Provision for credit losses	88	148
Depreciation	172	30
Net change of deferred loan origination costs	(223)	(148)
Net amortization of premiums & discounts on available-for-sale securities	(253)	118
Amortization of purchase accounting marks on loans	0	(465)
Amortization of core deposit intangible	98	109
Accretion of premium on FHLB advances	1	(11)
ESOP compensation expense	(202)	18
Earnings on bank owned life insurance	(9)	(10)
Change in assets and liabilities:
Net change in deferred taxes	569	234
Net change in accrued interest receivable	(246)	923
Net change in other assets	42	(3,524)
Net change in accrued expenses and other liabilities	2,035	(311)
Net cash provided by (used in) operating activities	3,801	(1,808)
Cash flows from investing activities:
Net change in loans receivable held for investment	(9,681)	(4,396)
Principal payments on available-for-sale securities	3,409	4,724
Purchase of available-for-sale securities	0	(26,908)
Purchase of FHLB stock	(1,765)	0
Proceeds from redemption of FHLB stock	0	351
Proceeds from redemption of FRB stock	1,721	0
Purchase of office properties and equipment	(3)	(67)
Net cash used in investing activities	(6,319)	(26,296)
Cash flows from financing activities:
Net change in deposits	(29,374)	51,662
Net change in securities sold under agreements to repurchase	7,470	4,043
Increase in unreleased ESOP shares	(2,500)	0
Dividends paid on preferred stock	0	(15)
Proceeds from FHLB advances	40,500	0
Repayments of FHLB advances	(35)	(13,000)
Net cash provided by financing activities	16,061	42,690
Net change in cash and cash equivalents	13,543	14,586
Cash and cash equivalents at beginning of the period	16,105	231,520
Cash and cash equivalents at end of the period	29,648	246,106
Supplemental disclosures of cash flow information:
Cash paid for interest	2,882	822
Cash paid for income taxes	0	0
Supplemental non-cash disclosures:
Common stock issued in exchange for preferred stock	0	3,000
Directors [Member]
Adjustments to reconcile net income to net cash provided by (used in) operating activities:
Stock-based compensation expense	96	84
Employees, Excluding Directors [Member]
Adjustments to reconcile net income to net cash provided by (used in) operating activities:
Stock-based compensation expense	$ 38	$ 15